skip to content

eLesor Investments version="1.1" id="Layer_1" xmlns="" xmlns:xlink="" x="0px" y="0px" viewBox="0 0 697.5 99.8" style="enable-background:new 0 0 697.5 99.8;" xml:space="preserve" aria-labelledby="title--mwlogoHeader desc--mwlogoHeader" role="img"> eLesor Site Logo A link that brings you back to the homepage.

Company Close Updates

TherapeuticsMD Inc. stock remains steady Thursday, underperforms market

Company Logo

Terrence Horan

Referenced Symbols

Shares of TherapeuticsMD Inc. TXMD, -3.85% were unchanged Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP, -0.71% rising 0.36% to 14,684.60 and the Dow Jones Industrial Average DJIA, -0.42% rising 0.07% to 34,823.35. TherapeuticsMD Inc. closed $1.69 short of its 52-week high ($2.75), which the company reached on February 9th.

The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson JNJ, +0.01% rose 0.29% to $169.98, Merck & Co. Inc. MRK, -0.08% rose 0.18% to $76.53, and Novartis AG ADR NVS, +0.22% rose 0.66% to $91.08. Trading volume (2.0 M) remained 3.8 million below its 50-day average volume of 5.8 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Partner Center